As demonstrated in the heat maps in Fig. 6A, the expression of TSPANs was closely related to numerous clinically relevant immune checkpoint molecules, again illustrating the high theoretical significance of developing novel immunotherapies for GBM through the TSPAN family. Here, TSPAN18 is linked to glioblastoma.